Thank you for that color Agent Smith, and Steve C.
I suppose there’s no sense in speculating, we’ll see soon enough.
If there are serious problems and massive duties, I cannot imagine this will be super popular with all the retirees who regularly import medications from abroad, but who knows, I’ve been surprised before.
The drop shippers are going to be the hardest hit.
Amazon is already cancelling their orders for “Amazon” products made in China.
This new process may curtail the “fast fashion” companies like Shein. Which in turn may reduce waste in the land fills. Just looking for the silver linings LoL!!
“Trump’s new tariffs on goods from India took effect on April 9, 2025. These tariffs, announced as part of a broader “Liberation Day” initiative on April 2, 2025, imposed a 26% duty on Indian imports, aimed at addressing trade imbalances and boosting U.S. manufacturing”.
Two things:
First: A 26% tariff on drugs from India will not change my buying habits because, even with the tariff, the drugs remain significantly cheaper than those sourced in the US.
Second: Since the Indian exporters typically lie about the cost of the goods, always valuing them at a fraction of the true cost, the duties will be minimal. And that is if the goods are actually inspected.
That’s a really good point. I ordered a Tixel 2 machine off Alibaba a few weeks ago but the tariff went from 10% to 20% while it was in transit, so I was anticipating a hefty duty collection. Once the package arrived I saw that it was declared as a vacuum cleaner valued at 5% of what I paid. 
Only then did I understand why the seller wasn’t worried about tariffs when I placed the order.
Gee, the only predictable thing about the US tariff policy is that it’s unpredictable. Now that we have a 90 day pause in tariffs (minus China), it’s time to perhaps complete your medication stockpile.
I’m thinking of putting in a couple more orders from India. There’s a window of opportunity, worth taking advantage of, IMHO. YMMV.
Yes. I’d use this window of opportunity ASAP. Stocking up a 2-4 year supply of meds may be prudent.
Who knows? Maybe a new president will get rid of the tarrifs?
Are most peptides like semaglutide sourced externally? I would say these are most critical.
Acarbose too.
Everything else equal, I’m more okay with a rapamycin drought than a semaglutide (or acarbose/SGLT2 inhibitor) drought.
Ugh now I’m concerned shirataki rice will get way more expensive
I’m wondering whether anyone can advise me: I just received my first shipment of Rapamycin from India (thank you, @desertshores for all the info you shared about how to do that! Maulik was great to work with), and now that the tariffs have gone wild, I’m eager to buy more during this 90-day pause or before things go even more off the deep end, but I’ve also read on this forum that it’s not a great idea to buy from India during the hot season, which is now, yes? I’m only buying Rapamycin, nothing else. Would you advise doing so now and ignoring the heat issue?
Under the circumstances, I am indeed taking a chance and have some orders coming in, and considering more. Keep in mind, that the weather, heat, are an issue at both ends. It’s hot right now in India. But still not very adverse in the US. So on balance that’s better than waiting until it’s hot both in India and the US. Usually, the package spends less time in India, while it can spend weeks in the USA, and travel in hot trucks. I live in California, so the USPS distribution hubs are in nightmarishly hot places like Arizona and Nevada, and central CA, so I’m especially sensitive to the heat issue stateside.
So weather wise, while not ideal, it’s still not the worst. I’m going ahead with my orders. YMMV.
There is no cool season in Mumbai, India, where most of my orders originate.
So, I try to at least not buy in the hot season of the Southwest, USA.
I just received my last order from India, and I will probably not order anything else from India until October.
The products from India apparently are not much worse for wear, as testified by the blood test results obtained by using India-sourced medications.
Well, the order I placed with Jagdish just went “Inbound Into Customs” as of 04/14/2025.
It’s just under $300. Now I’m curious to see if the 10% tariffs will apply to this package. I don’t know what Jagdish declared as the value, so we’ll see.
How long will it take to clear customs and if/what there will be any associated charges.
I’ll keep this updated.
I also have another package of the same meds being prepared by another vendor in India, so interesting what will happen there too.
UPDATE 1: the package has moved “Inbound Out of Customs” to “Jamaica NY International Distribution Center” so perhaps it’s at least out of customs and now it’s all about USPS doing their thing, hopefully smoothly.
So far, nothing different from every other package -
There is often a disjoint between what governments say is happening and what actually happens particularly when systems are changing. There are lots of reasons for this.
The only difference is that when we wrote “Obama” or “Obamacare” we didn’t have any fear openly expressing ourselves. Obama didn’t “hunt” those who disagreed with him. Now it’s different, isn’t it?
I asked this question in another thread but I’ll ask here…
I’m less worried about a tariff and more worried about China halting supplies.
I assume we should we safely assume that many of our US rx’s contain ingredients from China, right?
I’m thinking of using Good RX to buy a large quantity, maybe 12 months worth (is that too long regarding expiration dates? I assume it’s fine).
The only very expensive thing I use is Repatha. Due to that high cost, buying quantity does not sound appealing :). Of course a tariff on that would also be painful. Does anyone know how we can find out which drugs are sourced from China?
I’ve already reached out to my compounding pharmacy to find out what he might use.
no you are correct, the Obama admin only censored through social media, so who really knows who expressed themselves?
Its a really complex issue, to find out what drug (or drug components) are sourced from China; the Pharma companies in the USA are not likely to advertise this information.
China produces, I think, most (or at least a very large chunk of the APIs for generic meds) of the “APIs” , the “Active Pharmaceutical Ingredients” which are then purchased by the drug companies around the world to process into the final tablets, etc.
And most of the generic medications used in the USA are manufactured in India (I believe) and they source their APIs from China - so I don’t think the tariffs are not going to immediately stop us from getting generic medications given the supply chain linkages. And the tariffs on India are a lot lower, so that is a good thing.
But, I know of no way to figure out what the most at-risk pharmaceuticals are, but perhaps there are groups in the USA who are working this out and may publicize it.
And all the Gucci bags 
Living in China and knowing more about the Chinese government, I’d say you don’t have to worry about China not selling pharmaceutical related compounds. However you have to worry about the USA making them unbuyable by putting a 250%+ tariff on them.
That seems to be the thing I’d worry about. This is all getting quite ridiculous.
